RILUTEK

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug RILUTEK contains one active pharmaceutical ingredient (API):

1	Riluzole UNII 7LJ087RS6F - RILUZOLE
	Riluzole is proposed to act by inhibiting glutamate processes. The mode of action is unclear. It is suggested that glutamate (the primary excitatory neurotransmitter in the central nervous system) plays a role for cell death in the ALS disease.
	Read more about Riluzole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RILUTEK Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N07XX02	Riluzole	N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8664B
BR	Câmara de Regulação do Mercado de Medicamentos	502811101116311
CA	Health Products and Food Branch	02242763
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00426207, 00595855, 01607885, 07499770, 10276737, 10989986
EE	Ravimiamet	1035289
ES	Centro de información online de medicamentos de la AEMPS	96010001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	123992
FR	Base de données publique des médicaments	66292199
GB	Medicines & Healthcare Products Regulatory Agency	36847, 368734
HK	Department of Health Drug Office	42525
IE	Health Products Regulatory Authority	88150, 88734, 88891, 89013
IL	מִשְׂרַד הַבְּרִיאוּת	4299
IT	Agenzia del Farmaco	032887010
JP	医薬品医療機器総合機構	1190011F1021
LT	Valstybinė vaistų kontrolės tarnyba	1014212
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	133M97
NL	Z-Index G-Standaard, PRK	45225
NZ	Medicines and Medical Devices Safety Authority	7595
PL	Rejestru Produktów Leczniczych	100083164
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66040001
SG	Health Sciences Authority	09426P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699809090361
US	FDA, National Drug Code	70515-700
ZA	Health Products Regulatory Authority	30/34/0229